Welcome to GeneProof website!

It is great to see you here. To see all contents of the website, please register or restore your access.
We believe you will come back gladly.

GeneProof Team

 

User account
Forgot your password?
Searching

GeneProof Factor XIII V34L MC PCR Kit

CE IVD myCROBE® line

On this page you will find order codestechnical specifications and documents for the selected product.

Order information

Product name Catalog no. Technology Packaging
GeneProof Factor XIII V34L MC PCR Kit FXIII/MC/200 PCR for 180 tests

Technical specification

Indication in vitro diagnostic medical device
Regulatory Status  CE IVD / EC Directive 98/79/EC
Intended User For professional use in laboratories with trained staff
Test Principle Real-time polymerase chain reaction (PCR)
Type of Analysis Qualitative
Automated / Manual detection Automated
Target G103T Polymorphism in the F13A1 gene of Factor XIII (V34L) (rs5985)
Specificity Single nucleotide guanine/thymine polymorphism in the F13A1 gene of Factor XIII (V34L) at site 103 (rs5985))
Concentration Range 10-90 ng/µl
Negative Percentage Agreement 100 % (CI95%: 93,05 % - 100 %)
Positive Percentage Agreement 100 % (CI95%: 89,79 % - 100 %)
Overall Percentage Agreement 100 % (CI95%: 95,72 % - 100 %)
Validated Specimen Whole blood
Validated Extraction Methods myCROBE/croBEE 2.0 Universal Extraction Kit
Instruments

myCROBE® Fully Automated Instrument

Detection Channels FAM, HEX
External Quality Assessment Tested in Reference Institute for Bioanalytics Quality Assessment Panels - results at
www.geneproof.com

Instructions for Use

; GP_MC_FXIII_Instruction_for_Use_EN
pdf, [146.77 kB]

Declaration of Conformity

; GP_MC_FXIII_Declaration_of_Conformity_EN
pdf, [595.12 kB]

MSDS

; GP_MC_FXIII_Safety_Data_Sheet_EN
pdf, [273.64 kB]
Files are available only for registered users.

News

PCR Testing for the "Tripledemic"

GeneProof offers a unique PCR testing solution that provides differential diagnostics of many pathogens

GeneProof is IVDR Certified

Our products’ quality, safety, and performance are fully compliant with the new rules for in vitro…